This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Forbes
forbes.com
did:plc:2w45zyhuklwihpdc7oj3mi63
Analysts were critical of the Ozempic maker’s failed trial for a new experimental drug.
http://www.forbes.com/sites/tylerroush/2026/07/31/novo-nordisk-wipes-out-30-billion-in-market-value-after-failed-heart-drug-trial/?utm_campaign=forbes&utm_medium=social&utm_source=bluesky
2026-07-31T15:05:06.267Z